ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980

NCI Get Go-Ahead For New Cancer Control Projects Totaling $7.4 Million, Funded By Grants, Contracts

October 21, 1977

NIH Programs: Varmus Appoints 20 To Council of Public Representatives

April 30, 1999

In Brief: John Tamps New ACR President; Stanley Order ASTRO President Elect; Cairoli Heads Training

December 11, 1987

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

Turmoil in Texas: AVEO, DePinho Joined at the Hip (Pocket)

May 8, 2013